Evidence map›Paper›PMID 35056686›Full record

ArticleMolecules (Basel, Switzerland)2022

A New Oxygen Containing Pyclen-Type Ligand as a Manganese(II) Binder for MRI and

Tibor Csupász, Dániel Szücs, Ferenc Krisztián Kálmán, Oldamur Hollóczki, Anikó Fekete, Dezső Szikra, Éva Tóth, Imre Tóth, Gyula Tircsó

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Enhanced Tumor-to-Background Contrast with [Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Mn-Based MRI Contrast Agents: An Overview.Molecules (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Tibor CsupászDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0002-2345-6428
Dániel SzücsDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Ferenc Krisztián KálmánDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Oldamur HollóczkiDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Anikó FeketeDepartment of Medical Imaging, Division of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0002-0951-6092
Dezső SzikraDepartment of Medical Imaging, Division of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Éva TóthCentre de Biophysique Moléculaire, CNRS, Rue Charles Sadron, CEDEX 2, 45071 Orléans, France.ORCID 0000-0002-3200-6752
Imre TóthDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Gyula TircsóDepartment of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0002-7896-7890
University of Debrecen · HUCentre National de la Recherche Scientifique · FR

Funding

Doctoral School of Chemistry at the University of Debrecen DSC-UDHungarian National Research, Development and Innovation Office K-120224, K-128201, K-134694 and FK-134551János Bolyai Research Scholarship of the Hungarian Academy of Sciences F.K.K.the ÚNKP-21-4 new national excellence program of the Ministry of Human Capacities ÚNKP-21-4University of Debrecen Innovation Fund, POC-012
6 · The paper itself

Abstract

A new pyclen-3,9-diacetate derivative ligand (H

Indexed as

contrast agentsdissociation kineticsmacrocyclesmagnetic resonance imagingmanganeseradiochemistrystabilitywater exchange

Identifiers

PMID35056686
PMCPMC8778187
OpenAlexW4205298971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.